2025-05-28 - Analysis Report
Okay, here's an analysis of Intuitive Surgical (ISRG) based on the provided data.

**Executive Summary**

Intuitive Surgical Inc. (ISRG) specializes in robotic-assisted surgical systems. ISRG has significantly outperformed the S&P 500 in terms of cumulative returns, with a higher risk profile reflected in its historical volatility. Recent performance suggests a potential cooling-off period, but long-term outlook remains positive with strong revenue growth and high profitability.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (ISRG):** 133.20%
*   **Cumulative Return (VOO):** 83.14%
*   **Outperformance:** ISRG has outperformed VOO by 50.06 percentage points.
*   **Relative Deviation:** Current relative deviation is at 44.3 (on a scale of min -6.7 to max 121.5). This suggests that while ISRG has historically outperformed, its current position is closer to the lower end of its past outperformance range.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD   | Alpha | Beta | Cap(B) |
|------------|--------|-------|-------|------|--------|
| 2015-2017  | 68.0%  | 56.5% | 38.0% | 0.0  | 43.6   |
| 2016-2018  | 77.0%  | 63.4% | 60.0% | 0.0  | 57.2   |
| 2017-2019  | 81.0%  | 63.4% | 52.0% | 0.3  | 70.6   |
| 2018-2020  | 47.0%  | 63.4% | 22.0% | 0.2  | 97.7   |
| 2019-2021  | 91.0%  | 63.0% | 37.0% | 0.3  | 128.8  |
| 2020-2022  | -3.0%  | 69.9% | -9.0% | 0.3  | 95.1   |
| 2021-2023  | -5.0%  | 72.9% | -22.0% | 1.0  | 120.9  |
| 2022-2024  | 26.0%  | 72.9% | 9.0%  | 1.0  | 187.1  |
| 2023-2025  | 54.0%  | 72.9% | 23.0% | 0.7  | 197.2  |

**Analysis:**

*   **CAGR:** Fluctuating CAGR, indicating varied growth rates across different periods.
*   **MDD:** High Maximum Drawdown suggests significant risk and volatility.
*   **Alpha:** Generally positive Alpha values indicate outperformance relative to a benchmark, but recent years show negative Alpha, suggesting underperformance.
*   **Beta:** Beta values mostly around 0 indicate that the stock price is not much affected by the market.
*   **Capitalization:** Market capitalization shows a generally increasing trend, reflecting overall growth.

**2. Recent Price Movement**

*   **Current Price:** $550.19
*   **Previous Close:** $539.54
*   **Change:** 1.97% (Suggests a positive price movement)
*   **5-Day Moving Average:** 547.33
*   **20-Day Moving Average:** 543.19
*   **60-Day Moving Average:** 513.69

**Analysis:** The current price is above all moving averages, suggesting a short-term upward trend. The fact that the price moved up +1.97% from the previous close confirms it.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 61.96 (Approaching overbought territory, but not there yet)
*   **PPO:** -0.3637 (Slightly below zero, suggesting a mild downtrend in momentum)
*   **Hybrid Signal:** cash_69%_Sell 0.6% of holdings (1 shares - Caution - MRI:0.37) (Cash Ratio: 69% on 2025-05-27): Recommend to sell stocks.
*   **20-Day Relative Deviation Change:** -6.0 (Indicates recent underperformance relative to its historical deviation from the S&P 500)
*   **Expected Return:** 47.7% (Long-term estimated outperformance vs. S&P 500)

**Analysis:** The low MRI suggests a relatively stable market environment. RSI indicates the stock is nearing overbought conditions. The negative change in relative deviation suggests a recent weakening in performance compared to the S&P 500. The high expected return indicates optimism for long-term investors.

**4. Recent News & Significant Events**

*   **[2025-05-28]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-24]:** Analyst discussions of performance in context of industry trends and global economic factors.
*   **[2025-05-26]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-27]:** Market experts highlighting risks and opportunities.

**Analysis:** The news highlights both opportunities and volatility for ISRG. Investors should closely monitor company announcements, earnings reports, and analyst commentary.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2024-07-19 | 1.48 | 2.01 B$   |
| 2024-04-19 | 1.54 | 1.89 B$   |
| 2025-04-23 | 1.54 | 1.89 B$   |

**Analysis:** EPS and revenue show a generally increasing trend, indicating positive growth and profitability. The latest earnings report (2025-04-23) shows a significant jump in EPS and revenue.

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $2.25B   | 64.69%        |
| 2024-12-31 | $2.41B   | 68.04%        |
| 2024-09-30 | $2.04B   | 67.41%        |
| 2024-06-30 | $2.01B   | 68.30%        |
| 2024-03-31 | $1.89B   | 65.87%        |

**Capital and Profitability**

| Quarter    | Equity   | ROE    |
|------------|----------|--------|
| 2025-03-31 | $17.11B  | 4.08%  |
| 2024-12-31 | $16.43B  | 4.17%  |
| 2024-09-30 | $15.58B  | 3.63%  |
| 2024-06-30 | $14.71B  | 3.58%  |
| 2024-03-31 | $13.96B  | 3.90%  |

**Analysis:** Revenue is growing consistently, with strong profit margins. Equity is also increasing, indicating financial stability. ROE is relatively stable, showing consistent profitability on equity.

**7. Overall Analysis**

Intuitive Surgical (ISRG) demonstrates strong fundamentals with increasing revenue, high profit margins, and a history of outperforming the S&P 500. However, recent performance shows some signs of weakening, including a negative change in relative deviation and approaching overbought RSI levels. Market Risk Indicator shows low risk. Recent news suggests both opportunities and volatility. The hybrid signal indicates to sell stocks.

**Recommendation:**

Given the strong long-term outlook and high expected return, ISRG may still be a suitable investment for long-term investors willing to tolerate some volatility. However, recent weakening performance and approaching overbought RSI levels warrant caution. Investors may consider a more conservative approach, such as gradually accumulating shares. Monitoring upcoming earnings reports, news, and analyst commentary is crucial for making informed investment decisions.
